The first gene-editing therapies for HIV/Aids are entering trials but the virus is proving once again that it is a master at ...

In an ongoing clinical trial, researchers are testing whether just one dose of a new gene therapy that might effectively cure human immunodeficiency virus (HIV) infections is safe in humans. According ...

A research team at the Wuhan University of Science and Technology (WUST) has recently developed a new targeted delivery ...

HIV treatment has entered a revolutionary new era, one where a single yearly injection can keep the virus undetectable, and ...

In a provocative first step toward an elusive end to a devastating disease that has claimed 40 million lives, three patients have received CRISPR gene-editing therapies in an effort to eradicate HIV ...

The first trial to show that vaccination could confer HIV protection was the RV144 HIV vaccine trial. This trial reported an efficacy of 31%. A key element of the RV144 trial was gp120, generated in ...

Scientists are closer than ever to a functional HIV cure. This World AIDS Day, an expert breaks down what's real, what's hype ...

Tests in animal models by researchers at the Lewis Katz School of Medicine at Temple University, and at the University of Nebraska Medical Center (UNMC) have shown how gene editing two targets, HIV-1 ...

Share on Facebook (opens in a new window) Share on X (opens in a new window) Share on Reddit (opens in a new window) Share on Hacker News (opens in a new window) Share on Flipboard (opens in a new ...

Scientists at Excision BioTherapeutics are running a human clinical trial for a new CRISPR-based drug called EBT-101 which targets human immunodeficiency virus (HIV) infections. There are many tests ...

The concept of CRISPR gene-editing is still quite young. Although the discovery of CRISPRs themselves—repeating DNA sequences present in single-celled organisms, such as bacteria—can be traced back to ...